Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20497)

• Formulation Name: Sulindac 150 mg tablet
• Company: State of Florida DOH Central Pharmacy

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Sulindac	(DM2QHZU)	Acute myelogenous leukaemia	2A41	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant
Povidone	(E00667)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant